Lexicon Pharmaceuticals - Articles and news items

Sanofi and Lexicon collaborate on sotagliflozin

Industry news / 6 November 2015 / Victoria White

Sotagliflozin is an investigational new oral dual inhibitor of sodium-glucose cotransporters 1 and 2 which could be a potential treatment option for people with diabetes…

Positive top-line results for Phase 3 telotristat etiprate study

Industry news / 3 August 2015 / Victoria White

A Phase 3 clinical trial met its primary endpoint, showing the benefit of oral telotristat etiprate in treating cancer patients with carcinoid syndrome…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+